Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
C.36.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
C.36.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
C.36.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
C.36.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
C.36.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.36.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AN.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AN.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AN.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AN.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AN.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AN.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AN.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AN.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.28EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.28ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.177.28ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.177.28EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.177.28EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.28ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.28ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.221.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.221.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.221.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.221.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.221.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.221.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.221.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.221.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.242EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.242EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.242ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.242ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.242EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.242EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.242ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.242ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.81EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.81EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.81ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.81ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.81EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.81EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.81ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.81ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.258.24EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.258.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.24ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.258.24ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used